Drugmakers seek FDA emergency authorization for molnupiravir, antiviral pill to treat COVID-19

Posted on AllSides October 11th, 2021
From The Left

Pharmaceutical companies Merck & Co. and Ridgeback Biotherapeutics announced Monday the submission of emergency use authorization to the Food and Drug Administration for molnupiravir, an antiviral drug that offers the promise that COVID-19 could soon be treated by a pill.

Molnupiravir, an orally ingested antiviral pill, is used to treat mild to moderate adult cases of COVID-19 that are at risk of worsening to severe COVID-19 or hospitalization, according to the companies. It was created by researchers at Emory University in Atlanta and is given as four pills taken twice a day for five days.

An interim analysis from a clinical trial found the...

Read full story
Some content from this outlet may be limited or behind a paywall.

USA TODAY

AllSides Media Bias Rating: Lean Left
AllSides Media Bias Rating: Lean Left
106710/84317
See full bias rating for USA TODAY
Learn about media bias
https://www.usatoday.com/story/news/health/2021/10/11/covid-vaccinations-molnupiravir-antiviral-pill-cases/6083682001/

More News about Coronavirus from the Left, Center and Right

From the Left

From the Center

From the Right